Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Monoisotopic mass
315.183443671
InChI
InChI=1S/C19H25NO3/c21-18(20-12-15-8-4-5-9-16(15)13-20)11-17(19(22)23)10-14-6-2-1-3-7-14/h1-3,6-7,15-17H,4-5,8-13H2,(H,22,23)
InChI Key
InChIKey=WPGGHFDDFPHPOB-UHFFFAOYSA-N
IUPAC Name
2-benzyl-4-(octahydro-1H-isoindol-2-yl)-4-oxobutanoic acid
Traditional IUPAC Name
2-benzyl-4-(octahydroisoindol-2-yl)-4-oxobutanoic acid
SMILES
OC(=O)C(CC(=O)N1CC2CCCCC2C1)CC1=CC=CC=C1
pKa (strongest acidic)
4.62
pKa (Strongest Basic)
-0.15
Refractivity
88.31 m3·mol-1
Dược Lực Học :
Mitiglinide belongs to the meglitinide class of blood glucose-lowering drugs. It is approved for use in Japan but has not yet gained FDA approval.
Cơ Chế Tác Dụng :
Mitiglinide is a drug for the treatment of type 2 diabetes .Mitiglinide is thought to stimulate insulin secretion by closing the ATP-sensitive K(+) (K(ATP)) channels in pancreatic beta-cells.
Mitiglinide is thought to stimulate insulin secretion by binding to and blocking ATP-sensitive K(+) (K(ATP)) channels (Kir6.2/SUR1 complex, KATP channels) in pancreatic beta-cells. Closure of potassium channels causes depolarization which stimulates calcium influx through voltage-gated calcium channels. High intracellular calcium subsequently triggers the exocytosis of insulin granules.
Chỉ Định :
For the treatment of type 2 diabetes.